05:29 PM EDT, 10/03/2025 (MT Newswires) -- Joseph K Belanoff, Director, Chief Executive Officer, on October 01, 2025, sold 40,000 shares in Corcept Therapeutics ( CORT ) for $3,403,253. Following the Form 4 filing with the SEC, Belanoff has control over a total of 2,781,370 common shares of the company, with 2,781,370 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000119312525230467/xslF345X05/ownership.xml